RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
24. Januar 2022 07:00 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Jan. 24, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
New Patent on Software Games for Depression
29. August 2018 08:00 ET
|
Posit Science
SAN FRANCISCO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Posit Science, maker of BrainHQ online brain exercises and assessments, announced that it has been awarded a new patent by the US Patent Office — US...